Literature DB >> 8422866

Corpus callosotomy for seizures associated with band heterotopia.

H J Landy1, R G Curless, R E Ramsay, J Slater, C Ajmone-Marsan, R M Quencer.   

Abstract

Band heterotopia is a severe form of neuronal migration disorder associated with intractable epilepsy and neurologic impairment. Surgical treatment of seizures associated with this malformation has not been reported previously. We report a patient with band heterotopia and poorly controlled atonic seizures causing falls and injury. The patient was treated with anterior corpus callosotomy, with significant postoperative decrease in seizure frequency. Corpus callosotomy is a reasonable alternative to consider in management of patients with cortical heterotopia and intractable seizures.

Entities:  

Mesh:

Year:  1993        PMID: 8422866     DOI: 10.1111/j.1528-1157.1993.tb02379.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

1.  Non-pharmacological treatment options of drug-resistant epilepsy in subcortical band heterotopia: systematic review and illustrative case.

Authors:  Arthur R Kurzbuch; Ben Cooper; Anil Israni; Jonathan R Ellenbogen
Journal:  Childs Nerv Syst       Date:  2022-08-06       Impact factor: 1.532

2.  Callosotomy for intractable epilepsy from bihemispheric cortical dysplasias.

Authors:  R Pallini; S Aglioti; G Tassinari; G Berlucchi; C Colosimo; G F Rossi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Incremental changes in interhemispheric functional connectivity after two-stage corpus callosotomy in a patient with subcortical band heterotopia.

Authors:  Ako Matsuhashi; Takeshi Matsuo; Satoko Kumada
Journal:  Epilepsy Behav Rep       Date:  2022-01-22

4.  Spontaneous epileptiform activity in a rat model of bilateral subcortical band heterotopia.

Authors:  Surajit Sahu; Emmanuelle Buhler; Jean-Christophe Vermoyal; Françoise Watrin; Alfonso Represa; Jean-Bernard Manent
Journal:  Epilepsia       Date:  2018-12-30       Impact factor: 5.864

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.